Answers are grounded in this paper and cite their sources.
Background: Reinfection in the root canal and periradicular area due to the emergence of antibiotic resistance and/or multidrug-resistant strains of mixed colonization of multispecies periapical endodontic is the main reason for endodontic treatment failures. This has imposed a serious public health concern, contributing to decreased clinical efficiency and poor treatment outcomes. To combat these issues, “antimicrobial peptides are considered as potential alternatives and a promising agent” in endodontics. Objective: To evaluate and compare the antimicrobial efficiency of LL-37 peptide against periapical endodontic pathogens ( Streptococcus mutans, Lactobacillus salivarius, and Actinomyces naeslundii ). Methodology: A multispecies biofilm of S. mutans, L. salivarius, and Actinomyces naeslundii was created on 100 hydroxyapatite disks samples ( n = 100). Sixty samples ( n = 60) were allocated for the peptide group and 20 samples each ( n = 20) for the control group treated with disinfecting solution (sodium hypochlorite and normal saline). The minimum inhibitory concentration (MIC) and colony-forming units (CFUs) were assessed. Results: LL-37 peptides showed statistically significant correlation w.r.t CFUs and antimicrobial activity ( P < 0.01). Conclusion: LL-37 peptides were highly effective against periapical endodontic pathogens and hence could be used as a potential therapeutic agent in the future for endodontics.
No takes yet. Share an insight, caveat, or question.
Balaram et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: